These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2984441)

  • 1. Crisis in drug testing. Results of CDC blind study.
    Hansen HJ; Caudill SP; Boone DJ
    JAMA; 1985 Apr; 253(16):2382-7. PubMed ID: 2984441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse proficiency testing.
    Guerrant GO; Hall CT
    Clin Toxicol; 1977; 10(2):209-19. PubMed ID: 852242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fallibility of urine drug screens in monitoring methadone programs.
    Gottheil E; Caddy GR; Austin DL
    JAMA; 1976 Aug; 236(9):1035-8. PubMed ID: 989579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug screening.
    Frings CS
    CRC Crit Rev Clin Lab Sci; 1973 Dec; 4(4):357-82. PubMed ID: 4614940
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience in the identification of abuse drugs in urines collected under Treatment Alternatives to Street Crime.
    Cordova VF; Banford TA
    J Forensic Sci; 1975 Jan; 20(1):58-70. PubMed ID: 1117273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thin-layer chromatographic detection of barbiturates, narcotics, and amphetamines in urine of patients receiving psychotropic drugs.
    Heaton AM; Blumberg AG
    J Chromatogr; 1969 May; 41(3):367-70. PubMed ID: 5796330
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave assisted extraction of drugs of abuse from human urine.
    Fernández P; Lago M; Lorenzo RA; Carro AM; Bermejo AM; Tabernero MJ
    J Appl Toxicol; 2007; 27(4):373-9. PubMed ID: 17265433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of certain drugs of abuse in urine specimens.
    Frings CS; Queen CA
    Clin Chem; 1972 Nov; 18(11):1442. PubMed ID: 4652848
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
    Carlsson S; Olsson R; Lindkvist I; Beck O
    Scand J Clin Lab Invest; 2015 Apr; 75(2):156-61. PubMed ID: 25562730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmed identification of biotransformed drugs of abuse in urine.
    Baden MM; Valanju NN; Verma SK; Valanju SN
    Am J Clin Pathol; 1972 Jan; 57(1):43-51. PubMed ID: 5008893
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple method for the determination of dependence-producing drugs by gas chromatography.
    Maruyama Y; Sawa A; Hosoya E
    Bull Narc; 1975; 27(2):37-45. PubMed ID: 1041241
    [No Abstract]   [Full Text] [Related]  

  • 14. Status of drugs-of-abuse testing in urine under blind conditions: an AACC study.
    Frings CS; Battaglia DJ; White RM
    Clin Chem; 1989 May; 35(5):891-4. PubMed ID: 2720992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homogenous immunochemical drug assays.
    Bastiani RJ; Phillips RC; Schneider RS; Ullman EF
    Am J Med Technol; 1973 Jun; 39(6):211-6. PubMed ID: 4350742
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-activated chemical ionization ion trap mass spectrometry in the analysis of drugs in dilute urine samples. Part II: analysis of morphine and other street drugs.
    Cristoni S; Cantu M; Bernardi LR; Gerthoux P; Mocarelli P; Brambilla M; Gonella E; Guidugli F
    J Mass Spectrom; 2005 Dec; 40(12):1609-17. PubMed ID: 16320295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of techniques used to detect drugs of abuse in urine: study based on external quality assessment.
    Wilson JF; Williams J; Walker G; Toseland PA; Smith BL; Richens A; Burnett D
    Clin Chem; 1991 Mar; 37(3):442-7. PubMed ID: 2004454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse.
    Mulé SJ; Bastos ML; Jukofsky D
    Clin Chem; 1974 Feb; 20(2):243-8. PubMed ID: 4130418
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.
    Agius R; Nadulski T; Kahl HG; Dufaux B
    Drug Test Anal; 2013 Jun; 5(6):390-9. PubMed ID: 23349145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.